Urol. praxi, 2011; 12(4): 249-255

Urinary bladder diseases and their therapy

MUDr.Ladislava Lyerová, CSc.
Klinika nefrologie, IKEM, Praha

Urinary bladder diseases encompass a wide spectrum of conditions from clearly defined anatomic injury (e.g., by tumor, trauma, infection,

post-radiation injury) to more difficult-to-define functional control of urination (e.g., enuresis, incontinence). Bladder diseases present as

a variety of uncomfortable symptoms (dysuria, pollakiuria, nycturia) and, often, as a change in urine color (hematuria, pyuria). The most

frequent pathological entity affecting mostly women is infectious cystitis, both acute and recurrent or chronic. Likewise, more than 50 %

of women have to cope with some degree of incontinence, most often stress incontinence, at one or another point of their lifetime. In

cases where conservative therapy involving body weight reduction, exercise designed to strengthen the pelvic floor, pharmacotherapy

using, e.g., anticholinergics, and electrostimulation has failed, surgical management is opted for with moderate degrees of incontinence.

Techniques employing polypropylene bands (mini-invasive sling procedures) have been synonymous with a more up-to-date, rapid, and

less risk-associated approach to the treatment of stress-related incontinence. Another major group includes bladder tumors frequently

found in men and women and requiring costly and challenging therapy, most importantly because of high recurrence rates. Treatment of

the above conditions should only be undertaken by a erudite urologist with in close collaboration with other specialists from diagnostic

centers as well as from departments of oncology, gynecology, and nephrology.

Keywords: acute cystitis, recurent cystitis, neurogenic bladder, incontinence, bladder tumors

Published: August 10, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lyerová L. Urinary bladder diseases and their therapy. Urol. praxi. 2011;12(4):249-255.
Download citation

References

  1. Abrams P, Cardovo L, et al. The standardisation of terminology of lower urinary tract fuction: report from Standardisation Subcommitee of the International Continence Society. Neurourol Urodyn 2002: 21(2): 167-178. Go to original source... Go to PubMed...
  2. Broďák M, Navrátil P, Pacovský J, Louda M, Košina J, Holub L. Smyčkové operace stresové inkontinence moči u žen. Urolog. praxi, 2007; 8(6)
  3. Eichenauer RH, Vanherpe H. Anomálie měchýře a úrazy. Urologie - klinika a praxe, Scentia Medica 1996; 270-277.
  4. Fall M, Baranowski AP, Elneil S, et al. EAU guidelines on chronic pelvic pain. European Association of Urology Web site. http://www.uroweb.org/fileadmin/tx_eauguidelines/2009/Full/CPP.pdf. Updated March 2008.
  5. Guidelines Bladder Cancer Muscle-invasive and Metastatic. European Association of Urology Guidelines, 2009.
  6. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistence and management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001; (135): 41-50. Go to original source... Go to PubMed...
  7. Jakse G, Algaba F, Fossa S, et al. Guidelines EAU pro diagnostiku, klasifikaci a léčbu karcinomu močového měchýře Urol List 2004; (3): 84-95.
  8. Lyerová L, Teplan V. Role imunoterapie v profylaxi recidivujících infekcí močových cest Urolog. praxi 2010; 11(2): 65-68.
  9. Scholes D, Hooton TM, Roberts PL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000, 182: 1177-1182. Go to original source... Go to PubMed...
  10. Verner P. Porovnání účinnosti a vedlejších účinků anticholinergik při léčbě OAB. Urolog. praxi 2010: 11(5), 241-246.
  11. Zachoval R. Inkontinence moči. Urolog. praxi, 2003: 1, 25-27.
  12. Zámečník L. Inkontinence moči u žen v Hanuš T. a kol. Urologie. Lékařské repetitorium, Triton, 2011: 48-53.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.